A recent study suggests that patients who stop using blockbuster weight-loss injections like semaglutide or tirzepatide tend to recover lost weight far faster than those who end conventional diet and exercise programs.
Published data in a prominent health publication shows that while obese individuals frequently drop substantial amounts of their body weight while using the jabs, the mass returns at an estimated rate of nearly a kilo each month once they quit.
"Users buying these medications must be aware of the potential of rapid weight regain when the therapy is stopped," stated researcher Dr. Susan Jebb.
This pace of regain means a return to pre-treatment mass within about one and a half years.
Analyzing Treatments
The analysis, which reviewed 37 of studies involving over 9,000 of patients, compared the results of the injectable medications with conventional dieting.
Scientists note that people who shed pounds through lifestyle changes alone usually see a more gradual weight regain—around 0.1 kg a month—post-intervention.
Understanding the Rapid Rebound
Doctors believe the mode of action of the injections is key to understanding the heightened rebound.
The injections imitate a body's own chemical called GLP-1, which controls hunger.
"Sustained high doses of GLP-1 concentrations far above than the body's typical production may cause the body to produce less of its own natural hormone, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this hormone supplement results in appetite is uncontrolled, making excessive eating far more likely."
A Chronic Condition?
Medical guidelines recommend the injections for people with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
A number of clinicians argue that, given the likelihood of weight regain, the therapy is often ongoing.
This view is supported by drug manufacturers, who say that the results "emphasize the chronic nature of obesity," similar to managing diseases like hypertension.
User Accounts
Users who have come off the medication describe a powerful resurgence of hunger.
"It was like a trigger that goes on and you're instantly ravenous," described an individual.
The struggle is compounded if patients have not established lasting dietary or behavioural changes during treatment.
Growing Interest
Survey data show that millions of adults in the UK have used weight-loss jabs in the last 12 months, with desire continuing to grow.
- Adoption is more common among females compared to men.
- The 40s and 50s age group shows the highest level of interest.
- Many access the drugs through private healthcare rather than public health services.
Finally, researchers stress that while GLP-1 drugs are effective tools for weight loss, they are not a permanent cure and long-term success hinges on ongoing lifestyle management.
